Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Glucose Health, Inc. manufactures nutritional beverages for the diabetic-adult nutrition retail category. The Centers for Disease Control & Prevention today estimates 100 million Americans are pre-diabetic or Type-2 diabetic. GLUCODOWN is the first diabetic friendly beverage manufactured in North Am... Glucose Health, Inc. manufactures nutritional beverages for the diabetic-adult nutrition retail category. The Centers for Disease Control & Prevention today estimates 100 million Americans are pre-diabetic or Type-2 diabetic. GLUCODOWN is the first diabetic friendly beverage manufactured in North America enriched with a special form of soluble fiber clinically shown to help maintain healthy blood sugar and cholesterol levels. GLUCODOWN offer consumers a nutritious, functional beverage choice and is available in eight delicious flavors. GLUCODOWN is available in-store at pharmacies in all 50 States and online at Amazon (search GLUCODOWN). Mehr anzeigen
Glucose Health, Inc. Fiscal 2022 Annual Report BENTONVILLE Arkansas -- March 23, 2023 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC...
IMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC) Bentonville, AR -- November 3, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC...
Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022 BENTONVILLE AR -- October 24, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC:...
Glucose Health, Inc. Corporate Update BENTONVILLE, AR -- March 24, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") today...
Glucose Health, Inc. Corporate Update BENTONVILLE, AR -- March 17, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. ("Company") announced today, it has accepted...
Glucose Health, Inc. Fiscal 2021 Annual Report BENTONVILLE, AR -- February 10, 2022 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is...
Glucose Health, Inc. USPTO Patent Filing Asserts First Use of Nutritional Composition Underlying GLUCODOWN® BENTONVILLE, AR -- December 28, 2021 -- InvestorsHub...
Glucose Health, Inc. Fiscal 2021 Revenue Up 110% For Nine Month Period Ended September 30, 2021 BENTONVILLE, Arkansas -- November 3, 2021 -- Glucose Health, Inc. (OTC:...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.027 | -17.7631578947 | 0.152 | 0.1694 | 0.125 | 10352 | 0.13611411 | CS |
| 4 | -0.06735 | -35.0142968547 | 0.19235 | 0.2219 | 0.125 | 15544 | 0.16396084 | CS |
| 12 | -0.0761 | -37.8418697166 | 0.2011 | 0.2795 | 0.125 | 11208 | 0.1726731 | CS |
| 26 | -0.236 | -65.3739612188 | 0.361 | 0.479 | 0.125 | 8419 | 0.2375087 | CS |
| 52 | 0.034 | 37.3626373626 | 0.091 | 0.9001 | 0.091 | 15131 | 0.4132089 | CS |
| 156 | -2.08 | -94.3310657596 | 2.205 | 2.205 | 0.091 | 13650 | 0.68073021 | CS |
| 260 | 0.01365 | 12.2586439156 | 0.11135 | 8.98 | 0.069 | 31528 | 1.96780539 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
